Skip to main content
. 2022 Nov 2;3:1013921. doi: 10.3389/fgwh.2022.1013921

Figure 2.

Figure 2

VAS score among adenomyosis patients receiving treatment with LNG-IUS vs. systemic medication in randomized controlled studies.